Skip to main content
. 2020 May 7;10:45. doi: 10.1186/s13550-020-00635-z

Table 1.

Patient’s characteristics and indications for [99mTc]Tc-PSMA-I&S-SPECT/CT

N Age [years] Mean PSA [ng/ml]
Total 210 73 (± 8.5) 50 (± 270)
Indications
 biochemical recurrence (BCR) 152 (72.4%) 72.8 (± 8.8) 8.7 (± 32)
 primary staging in high-risk PCa 12 (5.7%) 72.7 (± 8.6) 393 (± 982)
 restaging in advanced recurrent PCa (antiandrogen therapy, chemotherapy, radiation therapy, 177Lu-PSMA therapy) 46 (21.9%) 74.2 (± 8.1) 101.3 (± 242)